Rallybio is a biotechnology company based in Farmington, CT, dedicated to revolutionizing the treatment of rare diseases by developing innovative therapies that go beyond conventional approaches.
With a team of experienced innovators and a robust pipeline of clinical and preclinical programs, Rallybio is committed to changing the narrative for patients with rare diseases, aiming to achieve profound outcomes and improve the odds for those in need.
Generated from the website